Philadelphia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Kehoe Law Firm, P.C. announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period").

Lead Plaintiff Deadline: September 28, 2026. Investors who acquired Capricor securities during the Class Period and suffered financial losses may move the court to be appointed lead plaintiff. Investors do not need to seek appointment as lead plaintiff to remain members of the proposed class or to share in any potential recovery.

Capricor Therapeutics Class Action Allegations

According to the class action complaint, Capricor and certain of its officers made materially false and/or misleading statements and failed to disclose material adverse facts about the Company's business, operations, and prospects, including:

• That Capricor changed the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel;
• That the U.S. Food and Drug Administration had not agreed to those changes before the Company resubmitted its Biologics License Application; and
• That the changes created a risk to the regulatory approval of Deramiocel for Duchenne muscular dystrophy-associated cardiomyopathy.

Capricor Investors May Have Legal Claims

Capricor investors who acquired securities during the Class Period and wish to learn more about the investigation and potential claims are encouraged to complete Kehoe Law Firm's Stockholder Information Request Form or contact:

There is no cost or obligation to speak with the firm. All representation is provided on a contingency-fee basis, and shareholders are not responsible for attorneys' fees, court costs, or litigation expenses. Any request for attorneys' fees and expenses will be subject to court approval.

ABOUT KEHOE LAW FIRM, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors and consumers in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.

This press release may constitute attorney advertising.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/309192